AI
FRTX

Ariel Investments’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History

Ariel Investments’s Portfolio FRTX Stock Details FRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-960
Closed -$438K – 166
2018
Q1 		$438K Sell
960
-1,065
-53% -$529K 0.01% 162
2017
Q4 		$1.17M Buy
2,025
+177
+10% +$117K 0.01% 165
2017
Q3 		$1.4M Buy
1,848
+624
+51% +$493K 0.02% 170
2017
Q2 		$1.02M Buy
1,224
+133
+12% +$97.3K 0.01% 178
2017
Q1 		$770K Sell
1,091
-393
-26% -$277K 0.01% 181
2016
Q4 		$1.07M Sell
1,484
-198
-12% -$161K 0.01% 185
2016
Q3 		$1.61M Buy
1,682
+3
+0.2% +$3.79K 0.02% 176
2016
Q2 		$2.4M Sell
1,679
-79
-4% -$102K 0.03% 165
2016
Q1 		$2.17M Sell
1,758
-449
-20% -$518K 0.03% 169
2015
Q4 		$2.85M Sell
2,207
-154
-7% -$201K 0.03% 164
2015
Q3 		$3.42M Sell
2,361
-7
-0.3% -$13.5K 0.04% 160
2015
Q2 		$5.22M Buy
2,368
+159
+7% +$499K 0.06% 150
2015
Q1 		$6.58M Buy
2,209
+151
+7% +$483K 0.07% 145
2014
Q4 		$6.81M Buy
2,058
+191
+10% +$676K 0.08% 139
2014
Q3 		$6.59M Buy
1,867
+27
+1% +$105K 0.09% 133
2014
Q2 		$7.07M Hold
1,840
– – 0.09% 135
2014
Q1 		$7.48M Sell
1,840
-402
-18% -$1.79M 0.09% 129
2013
Q4 		$8.33M Buy
2,242
+633
+39% +$2.4M 0.1% 123
2013
Q3 		$6.34M Sell
1,609
-21
-1% -$158K 0.09% 108
2013
Q2 		$16.1M Buy
+1,630
New +$18.1M 0.26% 66

Other funds holding FRTX

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ariel Investments's FRTX Position: Q2 2018 in Review

Ariel Investments sold out of Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) in Q2 2018, closing a stake of 960 shares — an estimated $438K sold.

Ariel Investments first reported a position in FRTX in Q2 2013 and held it in 20 quarters. The position peaked at $16.1M in Q2 2013. 28 funds tracked by Wall St. Rank hold FRTX as of Q2 2018.

  • Ariel Investments reported no remaining Fresh Tracks Therapeutics, Inc. Common Stock position as of Q2 2018 after selling out during the quarter.
  • Ariel Investments sold 960 Fresh Tracks Therapeutics, Inc. Common Stock shares in Q2 2018, an estimated $438K.
  • Ariel Investments first reported a position in Fresh Tracks Therapeutics, Inc. Common Stock in Q2 2013 and held it in 20 quarters.
  • Ariel Investments's Fresh Tracks Therapeutics, Inc. Common Stock position peaked at $16.1M in Q2 2013.
  • 28 funds tracked by Wall St. Rank held Fresh Tracks Therapeutics, Inc. Common Stock as of Q2 2018.

Based on Ariel Investments's 13F filing for Q2 2018, filed 10 Aug 2018.